ALPHARETTA, Ga., Sept. 20 /PRNewswire/ -- MedQuest Associates, Inc. and its subsidiaries and affiliates announced today that they have reached a settlement agreement with the U.S. Department of Justice (DOJ) to resolve the previously disclosed investigation into MedQuest's billing practices. MedQuest admitted no liability or wrongdoing in the settlement agreement.
The investigation arose from a lawsuit filed under seal according to the qui tam provision of the Federal False Claims Act. The DOJ thoroughly reviewed the claims made in that lawsuit and concluded that no government intervention was required in the matter. As a part of the settlement agreement, MedQuest will pay the U.S. government approximately $519,000 -- an extrapolated amount -- for alleged Medicare overpayments. In order to facilitate an expeditious resolution of the matter and to avoid further costs associated with protracted litigation, MedQuest also has entered into a separate, confidential settlement agreement with the private parties in the qui tam litigation, pursuant to which MedQuest agreed to pay an undisclosed and immaterial amount.
"We are very pleased to resolve this matter," said Donald C. Tomasso, MedQuest's Interim Chief Executive Officer. "The company's operating performance has remained strong thanks to our people and their commitment to quality patient care. It is great to close the book on this matter and to continue to move the company forward."
MedQuest Associates, Inc.CONTACT: MedQuest Associates, Inc., +1-202-277-2131